Corporate News 23-May-24
Piramal Pharma's Lexington facility completes USFDA inspection
Piramal Pharma announced that US FDA has issued an Establishment Inspection Report (EIR) for the its manufacturing facility located at Lexington, USA and the inspection has now been successfully closed by the US FDA.
Previous News
Nifty hovers around 18,250; PSU banks slide
( Market Commentary - Mid-Session 25-May-23 14:33 )
Piramal Pharma to convene board meeting
( Corporate News - 02-May-24 11:16 )
Piramal Pharma allots 12.96 cr equity shares on rights basis
( Corporate News - 22-Aug-23 17:55 )
Volumes spurt at Fine Organic Industries Ltd counter
( Hot Pursuit - 25-May-23 14:30 )
Piramal Pharma sizzles on turnaround Q4 performance
( Hot Pursuit - 25-May-23 13:26 )
Board of Piramal Pharma approves grant of 91.80 lakh stock options under
( Corporate News - 31-Jul-23 18:44 )
Everest Industries Ltd leads losers in 'B' group
( Hot Pursuit - 10-Nov-22 14:46 )
Piramal Pharma spurts after US facility gets EIR
( Hot Pursuit - 19-Apr-23 10:01 )
Piramal Pharma to conduct board meeting
( Corporate News - 29-Jul-23 17:22 )
Piramal Pharma gains on foraying into men’s grooming market in India
( Hot Pursuit - 10-Apr-24 15:44 )
Piramal Pharma jumps on reporting turnaround Q2 numbers
( Hot Pursuit - 30-Oct-23 10:25 )
Other Stories
GAIL (India) signs MoU with AM Green
04-Oct-24 19:27
EaseMyTrip.com resumes bookings to the Maldives
04-Oct-24 19:25
BLS completes acquisition of Dubai-based Citizenship Invest
04-Oct-24 19:23
Insecticides India launches new maize herbicide 'Torry Super'
04-Oct-24 19:21
Landmark Cars receives LoI from Mercedes-Benz India
04-Oct-24 19:19
Astra Microwave Products receives affirmation in credit ratings from CRISIL
04-Oct-24 19:16
Supreme Petrochem receives affirmation in credit ratings
04-Oct-24 19:10
Astec LifeSciences director resigns
04-Oct-24 19:08
Board of Gravita India approves change in directorate
04-Oct-24 19:05
Board of Gravita India approves fund raising up to Rs 1,000 cr
04-Oct-24 19:03
Back
Top
